Cargando…

Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: A network meta-analysis

BACKGROUND: It remains unclear which treatment is the most effective for previously treated patients with advanced esophageal and esophagogastric junction (EGJ) cancer. We conducted a network meta-analysis to address this important issue. METHODS: PubMed, Embase, Cochrane Library, and Web of Science...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shuiyu, Liu, Tingting, Chen, Jun, Li, Guang, Dang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177625/ https://www.ncbi.nlm.nih.gov/pubmed/34086780 http://dx.doi.org/10.1371/journal.pone.0252751

Ejemplares similares

Impact of Weight Loss on Patients with Locally Advanced Esophageal and Esophagogastric Junction Cancers Treated with Chemoradiotherapy
por: Wiwitkeyoonwong, Jirapath, et al.
Publicado: (2021)

Esophageal Stent for Cervical Esophagus and Esophagogastric Junction
por: Shim, Chan Sup
Publicado: (2012)

Accuracy of the endoscopic evaluation of esophageal involvement in esophagogastric junction cancer
por: Sakai, Takeshi, et al.
Publicado: (2021)

Comparative risk of serious and fatal treatment-related adverse events caused by 19 immune checkpoint inhibitors used in cancer treatment: a network meta-analysis
por: Liu, Tingting, et al.
Publicado: (2020)

Prognostic Value of Perineural Invasion in Esophageal and Esophagogastric Junction Carcinoma: A Meta-Analysis
por: Gao, Aiqin, et al.
Publicado: (2016)

Total Esophageal Avulsion at the Esophagogastric Junction after Blunt Trauma
por: Uygun, Ibrahim, et al.
Publicado: (2013)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
por: Cai, Ming-Zhi, et al.
Publicado: (2019)

Prognostic value of stem cell markers in esophageal and esophagogastric junction cancer: a meta-analysis
por: Trevellin, Elisabetta, et al.
Publicado: (2020)

Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance
por: Mikami, Hironobu, et al.
Publicado: (2018)

Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report
por: Furukawa, Kenichiro, et al.
Publicado: (2020)

A network meta-analysis of the short-term efficacy of five chemotherapy regimens based on cisplatin and fluorouracil for esophagogastric junctional adenocarcinoma
por: Wang, Cong, et al.
Publicado: (2017)

Effects of Metoclopramide on Esophageal Motor Activity and Esophagogastric Junction Compliance in Healthy Volunteers
por: Mikami, Hironobu, et al.
Publicado: (2016)

The Evaluation of Esophageal Endoscopic Findings in Patients with Functional Esophagogastric Junction Outflow Obstruction
por: Ochiai, Yorinari, et al.
Publicado: (2021)

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
por: Zhou, Zhangjian, et al.
Publicado: (2015)

Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2019)

Can proximal Gastrectomy Be Justified for Advanced Adenocarcinoma of the Esophagogastric Junction?
por: Sato, Yuya, et al.
Publicado: (2018)

Recent advances in multidisciplinary therapy for adenocarcinoma of the esophagus and esophagogastric junction
por: Zheng, Yi-Han, et al.
Publicado: (2022)

Prognostic impact of sarcopenia in patients with locally advanced adenocarcinoma of the esophagogastric junction treated with neoadjuvant chemoradiotherapy
por: Ming, Jiao, et al.
Publicado: (2023)

Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction
por: Nagami, Yasuaki, et al.
Publicado: (2014)

Hypotonic Upper Esophageal Sphincter With Functional Esophagogastric Junction Obstruction in a Patient With Oropharyngeal and Esophageal Dysphagia
por: Park, Moo In
Publicado: (2011)

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
por: Li, Shengli, et al.
Publicado: (2023)

Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China
por: Zhang, Hao, et al.
Publicado: (2013)

Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction
por: Tian, Yuan, et al.
Publicado: (2021)

Clinical significance of signet ring cells in surgical esophageal and esophagogastric junction adenocarcinoma: A systematic review and meta-analysis
por: Wang, Yi-Fan, et al.
Publicado: (2021)

Safety, efficacy, and selection strategy of laparoscopic local gastrectomy for gastrointestinal stromal tumors in the esophagogastric junction
por: Zhang, Haiqiao, et al.
Publicado: (2022)

Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022)

Multimodal treatments for resectable esophagogastric junction cancer: a systematic review and network meta-analysis
por: Cheng, Ji, et al.
Publicado: (2019)

Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma
por: Tang, Weifeng, et al.
Publicado: (2019)

Trends in esophageal and esophagogastric junction cancer research from 2007 to 2016: A bibliometric analysis
por: Miao, Yan, et al.
Publicado: (2017)

Esophageal Bolus Domain Pressure and Peristalsis Associated With Experimental Induction of Esophagogastric Junction Outflow Obstruction
por: Lei, Wei-Yi, et al.
Publicado: (2022)

Pembrolizumab versus paclitaxel for previously treated, advanced gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized clinical trials
por: Swed, Sarya, et al.
Publicado: (2022)

Comparative efficacy and safety for different chemotherapy regimens used concurrently with thoracic radiation for locally advanced non-small cell lung cancer: a systematic review and network meta-analysis
por: Liu, Tingting, et al.
Publicado: (2019)

Current surgical treatment of esophagogastric junction adenocarcinoma
por: Zhang, Shun, et al.
Publicado: (2019)

Esophagogastric Junction Outflow Obstruction Caused by Gabapentin
por: Barret, Maximilien, et al.
Publicado: (2019)

Patients unfit for neoadjuvant therapy may still undergo resection of locally advanced esophageal or esophagogastric junctional cancer with acceptable oncological results
por: O’Neill, J. Robert, et al.
Publicado: (2017)

The Impact of Magnetic Sphincter Augmentation (MSA) on Esophagogastric Junction (EGJ) and Esophageal Body Physiology and Manometric Characteristics
por: Ayazi, Shahin, et al.
Publicado: (2023)

Hub genes in adenocarcinoma of the esophagogastric junction based on weighted gene co-expression network analysis and immunohistochemistry
por: Lai, Zhiyong, et al.
Publicado: (2023)

Survival benefit of anti-angiogenic agents in patients with previously treated advanced gastric or gastroesophageal junction cancer: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017)

Does Sedation Affect Examination of Esophagogastric Junction during Upper Endoscopy?
por: Lee, Hyun Jik, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lehj1cmabq5danv0gkd6nhniie